Inspires curiosity and a love for knowledge.
This comment is not public.
Associate Professor Thomas Nathow is Head of the Ipswich Clinical Unit and Head of the West Learning Community in The University of Queensland Medical School, overseeing clinical education and training for medical students within the Greater Brisbane Clinical School. Located at 1 Court Street, Ipswich, Queensland, the unit under his leadership supports the Doctor of Medicine program through hands-on clinical placements and teaching. He has been recognized with the UQ Medical Program Teaching Award for the Ipswich Clinical Unit, highlighting his dedication to medical education.
Thomas Nathow graduated from the University of Leipzig in 1997 with a medical degree. He completed advanced training in Internal Medicine, obtaining further qualifications in sleep medicine and emergency medicine. After a voluntary year as Senior House Officer in the emergency departments of Caboolture Hospital and Redcliffe Hospital, he joined Ipswich General Hospital as Consultant Physician in General Medicine in 2008 and received Fellowship of the Royal Australasian College of Physicians in 2010. Practicing at Mater Private Hospital Springfield, his clinical interests encompass acute and subacute management of medical patients, diabetes, and endocrinology. He supervises junior doctors and third-year medical students from The University of Queensland. In 2014, he founded the Ipswich Research Institute to connect local patients with national and international research projects, collaborating with researchers and pharmaceutical companies. His contributions to research include co-authorship on clinical trials such as the BRIGHT study, 'Effect of Insulin Glargine Up-titration vs Insulin Degludec Once Daily on Glycemic Control Accompanying Treatment With Metformin in Type 2 Diabetes,' published in JAMA in 2016; a randomised, placebo-controlled clinical trial in Diabetologia in 2018; and a safety and pharmacodynamics study of temelimab in Diabetes, Obesity and Metabolism in 2020. These works demonstrate his impact on advancing diabetes management strategies.
